IFNA17 and rheumatoid arthritis: The suppression of TNF production in diseases such as rheumatoid arthritis (RA), which requires anti-TNF treatment, disrupts this equilibrium, leading to the inhibition of DC maturation and the production of excessive amounts of IFN-α/β [68,69].